Hematopoietic stem cell transplantation with umbilical cord multipotent stromal cell infusion for the treatment of aplastic anemia—a single-center experience-Reference-Cited by-同舟云学术

Hematopoietic stem cell transplantation with umbilical cord multipotent stromal cell infusion for the treatment of aplastic anemia—a single-center experience

Published:2013-09 Issue:9 Volume:15 Page:1118-1125
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Wang Hengxiang,Wang Zhidong,Zheng Xiaoli,Ding Li,Zhu Ling,Yan Hongmin,Guo Zikuan

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference43 articles.

1. Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy: the European Group for Blood and Marrow Transplantation experience;Bacigalupo;Semin Hematol,2000

2. G-CSF-primed haploidentical marrow transplantation without ex vivo T cell depletion: an excellent alternative for high-risk leukemia;Ji;Bone Marrow Transplant,2002

3. Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation;Lu;Blood,2006

4. Haploidentical hematopoietic stem cell transplantation in children hematologic malignancies with G-CSF mobilized marrow grafts without T cell depletion: a single center report of 45 cases;Wang;Pediatr Hematol Oncol,2009

5. Transplantation of CD34-enriched peripheral stem cells from an HLA-haplotype mismatched donor to a patient with severe aplastic anemia;Kremens;Bone Marrow Transplant,2001

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Umbilical cord blood derived cellular therapy: advances in clinical development;Frontiers in Oncology;2023-05-18

2. Successful desensitization of high level donor-specific anti-HLA antibody in patients with hematological diseases receiving haploidentical allografts;Annals of Hematology;2022-06-21

3. Wharton’s jelly‐derived stromal cells and their cell therapy applications in allogeneic haematopoietic stem cell transplantation;Journal of Cellular and Molecular Medicine;2022-01-28

4. Feasibility of reduced-dose posttransplant cyclophosphamide and cotransplantation of peripheral blood stem cells and umbilical cord-derived mesenchymal stem cells for SAA;Scientific Reports;2021-01-08

5. Current Status and Future Prospects of Perinatal Stem Cells;Genes;2020-12-23